HRPK931105B1 - Mesenchymal regeneration by the use of hypolipemics, esters of aryloxycarbonic acid derivatives in mucocutaneous diseases, neurological diseases, diseases of locomotor system, ocular diseases, mesenchymal tumors, viral diseases and against aging - Google Patents

Mesenchymal regeneration by the use of hypolipemics, esters of aryloxycarbonic acid derivatives in mucocutaneous diseases, neurological diseases, diseases of locomotor system, ocular diseases, mesenchymal tumors, viral diseases and against aging

Info

Publication number
HRPK931105B1
HRPK931105B1 HRP931105AA HRP931105A HRPK931105B1 HR PK931105 B1 HRPK931105 B1 HR PK931105B1 HR P931105A A HRP931105A A HR P931105AA HR P931105 A HRP931105 A HR P931105A HR PK931105 B1 HRPK931105 B1 HR PK931105B1
Authority
HR
Croatia
Prior art keywords
diseases
mesenchymal
neurological
hypolipemics
regeneration
Prior art date
Application number
HRP931105AA
Other languages
Croatian (hr)
Inventor
Gligora Mario
Original Assignee
Gligora Mario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gligora Mario filed Critical Gligora Mario
Priority to HRP931105AA priority Critical patent/HRPK931105B1/en
Priority to SI9400395A priority patent/SI9400395A/en
Publication of HRP931105A2 publication Critical patent/HRP931105A2/en
Publication of HRPK931105B1 publication Critical patent/HRPK931105B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Regeneracija mezenhima uporabom hipolipemika, estera derivata ariloksikarbonskih kiselina u mukokutanim bolestima, neurološkim bolestima, bolestima lokomotornog aparata, bolestima oka, mezenhimalnim tumorima, virusnim bolestima i protiv starenja naznačena time, što su derivati ariloksikarbonskih kiselina, u prvom redu klofibrat i fenofibrat i nova generacija ovih derivata (bezafibrat, gemfibrosil etc.) uspješno primijenjeni u liječenju kroničnih rana različite etiologije, zatim u trofičnih i verikoznih ulkusa potkoljenica i stopala, kao i kod perianalnih ulkusa oboljelih od AIDS-a, kod ozeblina (posebice u njihovoj profilaksi), u strija i tzv. cellulitisa, kod necrobiosis lipoidica, limfedema, kod akutnih i kroničnih oblika pruritisa različite etiologije, anetodermija, kod paradentoze, zatim kao antagonist kortikosteroida, ali i kod neuroloških atrofija kože i potkožja, bolestima lokomotornog aparata i bolestima oka (ulkus rožnice), kod sistemskih bolesti veziva i histiocitoze X (Granuloma eosinophylicum disseminatum), kod mezenhimalnih tumora, tj. u bolestima gdje je oštečenje mezenhima primarno ili je posljedica temeljne bolesti, a u trećoj životnoj dobi kao pripomoć u revitalizaciji.Konsenzualni patent sadrži još 3 patentna zahtjeva.Mesenchymal regeneration using hypolipemics, aryloxycarboxylic acid ester derivatives in mucocutaneous diseases, neurological diseases, diseases of the locomotor apparatus, eye diseases, mesenchymal tumors, viral diseases and anti-aging, characterized in that the derivatives of aryloxycarboxylic acids and, first and foremost, are cloenofibrate derivatives (bezafibrate, gemfibrosil, etc.) successfully used in the treatment of chronic wounds of different etiology, then in trophic and veic ulcers of the lower legs and feet, as well as in perianal ulcers of AIDS, frostbite (especially in their prophylaxis), in stretch marks and so called. cellulitis, necrobiosis lipoidica, lymphedema, acute and chronic forms of pruritus of different etiology, anetoderma, paradentosis, antagonist of corticosteroids, but also neurological atrophies of the skin and subcutaneous tissue, locomotor apparatus diseases and diseases of the eye (corneal ulcer) binders and histiocytosis X (Granuloma eosinophylicum disseminatum), in mesenchymal tumors, ie in diseases where mesenchymal damage is primary or due to underlying disease, and in the third age as an aid in revitalization.The consensual patent contains 3 more patent claims.

HRP931105AA 1993-10-25 1993-10-25 Mesenchymal regeneration by the use of hypolipemics, esters of aryloxycarbonic acid derivatives in mucocutaneous diseases, neurological diseases, diseases of locomotor system, ocular diseases, mesenchymal tumors, viral diseases and against aging HRPK931105B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HRP931105AA HRPK931105B1 (en) 1993-10-25 1993-10-25 Mesenchymal regeneration by the use of hypolipemics, esters of aryloxycarbonic acid derivatives in mucocutaneous diseases, neurological diseases, diseases of locomotor system, ocular diseases, mesenchymal tumors, viral diseases and against aging
SI9400395A SI9400395A (en) 1993-10-25 1994-10-25 Aryloxycarbonic acid derivates and their use for mezenhim's regeneration.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HRP931105AA HRPK931105B1 (en) 1993-10-25 1993-10-25 Mesenchymal regeneration by the use of hypolipemics, esters of aryloxycarbonic acid derivatives in mucocutaneous diseases, neurological diseases, diseases of locomotor system, ocular diseases, mesenchymal tumors, viral diseases and against aging

Publications (2)

Publication Number Publication Date
HRP931105A2 HRP931105A2 (en) 1996-06-30
HRPK931105B1 true HRPK931105B1 (en) 2001-04-30

Family

ID=10945998

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP931105AA HRPK931105B1 (en) 1993-10-25 1993-10-25 Mesenchymal regeneration by the use of hypolipemics, esters of aryloxycarbonic acid derivatives in mucocutaneous diseases, neurological diseases, diseases of locomotor system, ocular diseases, mesenchymal tumors, viral diseases and against aging

Country Status (2)

Country Link
HR (1) HRPK931105B1 (en)
SI (1) SI9400395A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716338A (en) * 2012-06-29 2012-10-10 遵义臻坤中草医药研究所 Traditional Chinese medicine composition for activating human body dormancy stem cells and delaying senium

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716338A (en) * 2012-06-29 2012-10-10 遵义臻坤中草医药研究所 Traditional Chinese medicine composition for activating human body dormancy stem cells and delaying senium

Also Published As

Publication number Publication date
HRP931105A2 (en) 1996-06-30
SI9400395A (en) 1995-04-30

Similar Documents

Publication Publication Date Title
ATE232093T1 (en) USE OF FUMARIC ACID DERIVATIVES TO TREAT AUTOIMMUNE DISEASES
PT716600E (en) COMPOSITIONS FOR TOP ADMINISTRATION CONTAINING DERIVATIVES OF 3-BENZOYLPHENYLIC ACID FOR THE TREATMENT OF INFLAMMATORY DISEASES OF OPHTHALMIC
DE3850109D1 (en) 13-TRANS RETIC ACID ESTER.
ES2166783T3 (en) ACTIVATED FACTOR VIII USED AS A THERAPEUTIC AGENT AND METHOD FOR THE TREATMENT OF FACTOR DEFICIENCY VIII.
DE69123960D1 (en) TREATMENT OF INFLAMMATION
ES2136599T3 (en) WOUND TREATMENT USING BIOLOGICALLY ACTIVE PEPTIDES.
DE69822295D1 (en) USE OF MISOPROSTOL AND / OR MISOPROSTOLIC ACID FOR THE TREATMENT OF ERECTIONAL DISORDERS
HRPK931105B1 (en) Mesenchymal regeneration by the use of hypolipemics, esters of aryloxycarbonic acid derivatives in mucocutaneous diseases, neurological diseases, diseases of locomotor system, ocular diseases, mesenchymal tumors, viral diseases and against aging
ATE114470T1 (en) TREATMENT OF INTRAOCULAR PRESSURE WITH A SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
ES2095578T3 (en) COMPOSITION FOR THE TREATMENT OF MASTITIS AND METRITIS.
DE69633233D1 (en) MULTIVALENT VACCINE AGAINST BOVINES CORONAVIRUS AND METHOD FOR TREATING AN INFECTION WITH BOVIN CORONAVIRUS
ES2074623T3 (en) USE OF AMINO ACIDS FOR THE PROTECTION OF ISCHEMIC CARDIAC TISSUES AND THEIR METABOLIC RECOVERY.
EP0641201A4 (en) Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids.
ES2084348T3 (en) N - ((4,5-DIHIDROXI- Y 4,5,8-TRIHIDROXI-9,10-DIHIDRO-9,10-DIOXO-2-ANTRACEN-IL) CARBONIL) AMINO ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES.
ES2163450T3 (en) USE OF BENZIDAMINE IN THE TREATMENT OF PATHOLOGICAL STATES CAUSED BY TNF.
CH448065A (en) Process for the preparation of sulphonation mixtures of fatty acids and their derivatives, in particular of fatty acid esters, and for working up these mixtures
MY100443A (en) Topical preparation for treating herpes simplex virus infection
DK0380036T3 (en) Vaginal suppository
SU676618A1 (en) Old leather restoring method
ATE254919T1 (en) USE OF PENCICLOVIR TO TREAT HUMAN HERPES VIRUS-8
SU1124944A1 (en) Method of treatment of paralytic unstable hip joint
SU1653744A1 (en) Device for executing laparoscopy
SU668681A1 (en) Contraction treatment method
Tenenbaum Turpentine by Injection in Dermatology and Urology
Smith Skin graft for the ambulatory patient

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
ODRP Renewal fee for the maintenance of a patent

Payment date: 20001025

Year of fee payment: 9

PNAN Change of the applicant name, address/residence

Owner name: MARIO GLIGORA, HR

PKB1 Consensual patent granted
AIPK Request for the grant of a patent on the basis of a substantive examination of a patent application after grant of consensual patent
ODBI Application refused